142 related articles for article (PubMed ID: 22374550)
1. Malignant induction probability maps for radiotherapy using X-ray and proton beams.
Timlin C; Houston M; Jones B
Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S70-8. PubMed ID: 22374550
[TBL] [Abstract][Full Text] [Related]
2. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
3. 3D calculation of radiation-induced second cancer risk including dose and tissue response heterogeneities.
Timlin C; Warren DR; Rowland B; Madkhali A; Loken J; Partridge M; Jones B; Kruse J; Miller R
Med Phys; 2015 Feb; 42(2):866-76. PubMed ID: 25652499
[TBL] [Abstract][Full Text] [Related]
4. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
[TBL] [Abstract][Full Text] [Related]
5. Radiobiology with heavy charged particles: a historical review.
Skarsgard LD
Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
[TBL] [Abstract][Full Text] [Related]
6. Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques.
Purdy JA
Health Phys; 2008 Nov; 95(5):666-76. PubMed ID: 18849701
[TBL] [Abstract][Full Text] [Related]
7. Treatment planning of intensity modulated composite particle therapy with dose and linear energy transfer optimization.
Inaniwa T; Kanematsu N; Noda K; Kamada T
Phys Med Biol; 2017 Jun; 62(12):5180-5197. PubMed ID: 28333688
[TBL] [Abstract][Full Text] [Related]
8. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
[TBL] [Abstract][Full Text] [Related]
9. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
[TBL] [Abstract][Full Text] [Related]
10. Improving the dose distributions in minibeam radiation therapy: Helium ions vs protons.
Schneider T; Patriarca A; Prezado Y
Med Phys; 2019 Aug; 46(8):3640-3648. PubMed ID: 31173369
[TBL] [Abstract][Full Text] [Related]
11. Optimization of radiobiological effects in intensity modulated proton therapy.
Wilkens JJ; Oelfke U
Med Phys; 2005 Feb; 32(2):455-65. PubMed ID: 15789592
[TBL] [Abstract][Full Text] [Related]
12. Intensity modulated radiation therapy using laser-accelerated protons: a Monte Carlo dosimetric study.
Fourkal E; Li JS; Xiong W; Nahum A; Ma CM
Phys Med Biol; 2003 Dec; 48(24):3977-4000. PubMed ID: 14727747
[TBL] [Abstract][Full Text] [Related]
13. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
[TBL] [Abstract][Full Text] [Related]
14. The effect of radiation quality on the risks of second malignancies.
Manem VS; Kohandel M; Hodgson DC; Sharpe MB; Sivaloganathan S
Int J Radiat Biol; 2015 Mar; 91(3):209-17. PubMed ID: 25356906
[TBL] [Abstract][Full Text] [Related]
15. Proton beams to replace photon beams in radical dose treatments.
Suit H; Goldberg S; Niemierko A; Trofimov A; Adams J; Paganetti H; Chen GT; Bortfeld T; Rosenthal S; Loeffler J; Delaney T
Acta Oncol; 2003; 42(8):800-8. PubMed ID: 14968940
[TBL] [Abstract][Full Text] [Related]
16. Optimization of beam arrangements in proton minibeam radiotherapy by cell survival simulations.
Sammer M; Greubel C; Girst S; Dollinger G
Med Phys; 2017 Nov; 44(11):6096-6104. PubMed ID: 28880369
[TBL] [Abstract][Full Text] [Related]
17. Imaging issues specific to hadrontherapy (proton, carbon, helium therapy and other charged particles) for radiotherapy planning, setup, dose monitoring and tissue response assessment.
Thariat J; Hérault J; Beddok A; Feuvret L; Dauvergne D; Gérard M; Balosso J; Noël G; Valable S
Cancer Radiother; 2020 Aug; 24(5):429-436. PubMed ID: 32247687
[TBL] [Abstract][Full Text] [Related]
18. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
19. TPD-based evaluation of near threshold mono-energetic proton energies for the (7)Li(p,n)(7)Be production of neutrons for BNCT.
Bengua G; Kobayashi T; Tanaka K; Nakagawa Y; Unesaki H
Phys Med Biol; 2006 Aug; 51(16):4095-109. PubMed ID: 16885627
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
